Commonwealth Laboratories, LLC (“Commonwealth”) is a state and federally licensed, CLIA-certified, FDA-registered independent clinical laboratory specializing in assisting our physicians and patients with the diagnosis of some of the common sources of digestive distress and functional GI disorders.
Our hydrogen and methane breath testing services provide a fast, reliable and convenient diagnostic tool for identifying Small Intestinal Bacterial Overgrowth (SIBO), a leading cause of the symptoms associated with Irritable Bowel Syndrome (IBS), as well as other digestive disorders including Lactose Intolerance, Fructose Intolerance, Sucrose Intolerance and Helicobacter Pylori (H. Pylori). Commonwealth provides an easy-to-use take-home test kit that allows patients to administer the test and collect the specimens in the comfort of their own home.
Most recently, Commonwealth introduced IBSchek™, a new blood test designed to help physicians quickly and reliably diagnose Irritable Bowel Syndrome. IBSchek is based on the scientific findings of Mark Pimentel, MD, which showed that anti-vinculin and anti-CdtB are effective biomarkers for the diagnosis of diarrhea-prominent IBS. The test utilizes a proprietary, ELISA-based blood test, providing results within 24 hours of sample receipt at Commonwealth.